Xanthomatosis and extreme hypercholesterolemia after laparoscopic cholecystectomy. Total reversibility following surgical treatment of iatrogenous stenosis of the common bile duct;Extrém hypercholesteriaemia és xanthomatosis laparoszkópos cholecystectomia után. Teljes reversibilitás az iatrogén szukület mutéti megoldását követoen

Orvosi Hetilap

Volumn 147, Issue 15, 2006, Pages 705-710

  Csák, Tímea ^a,b   Folhoffer, Anikó ^a   Horváth, Andrea ^a   Osztovits, János ^a   Görög, Dénes ^b   Kóbori, László ^b   Papp, János ^a   Szalay, Ferenc ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b Transzplantációs és Sebészeti Klinika ^*  (Hungary)

Author keywords

Anticholesterol antibody; Extrahepatic bile duct obstruction; Extreme hypercholesterolemia; Laparoscopic cholecystectomy; Xanthomatosis

Indexed keywords

ANTIBODY; BILIRUBIN; CHOLESTEROL; CHOLESTEROL ANTIBODY; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ANTIBODY DETECTION; ARTICLE; BILE LEAKAGE; BILIRUBIN BLOOD LEVEL; CASE REPORT; CHOLECYSTECTOMY; CHOLEDOCHOJEJUNOSTOMY; CHOLESTASIS; CHOLESTEROL BLOOD LEVEL; COMMON BILE DUCT STENOSIS; CONTROLLED STUDY; DISEASE SEVERITY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; EXTRAHEPATIC BILE DUCT OBSTRUCTION; FEMALE; GALLSTONE; HUMAN; HYPERCHOLESTEROLEMIA; LABORATORY TEST; POSTOPERATIVE PERIOD; TRIACYLGLYCEROL BLOOD LEVEL; XANTHOMATOSIS; COMMON BILE DUCT; COMMON BILE DUCT DISEASE; LIVER CIRRHOSIS; OBSTRUCTIVE JAUNDICE; PATHOLOGY; STENOSIS, OCCLUSION AND OBSTRUCTION;

ADULT; CHOLECYSTECTOMY, LAPAROSCOPIC; CHOLESTASIS, EXTRAHEPATIC; COMMON BILE DUCT; COMMON BILE DUCT DISEASES; CONSTRICTION, PATHOLOGIC; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; LIVER CIRRHOSIS; XANTHOMATOSIS;

EID: 33745618742     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Bolukhas, C, Bolukhas, F. F., Horoz, M. és mtsai: Magnetic resonance cholangiopancreatography in cholestatic diseases. Hepatogastroenterology, 2005, 52, 705-708.
2. Buckley, D. A., Higgins, E. M., du Vivier, A. W.: Resolution of xanthomas in Alagille syndrome after liver transplantation. Pediatr. Dermatol., 1998, 15, 199-202.
3. Dhingra, S., Bansal, M. P.: Hypercholesterolemia and apolipoprotein B expression: Regulation by selenium status. Lipids in Health and Disease, 2005, 4, 28-41.
4. Fagan, A. M., Christopher, E., Taylor, J. W. és mtsai: ApoAI deficiency in marked reductions in plasma cholesterol but no alterations in amyloid-beta pathology in a mouse model of Alzheimer's disease-like cerebral amyloidosis. Am. J. Pathol., 2004, 165, 1413-1422.
5. Hammel, P., Couvelard, A., O'Toole, D. és mtsai: Regression of liver fibrosi after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct. N. Engl. J. Med., 2001, 344, 418-423.
6. Harty, M. W., Huddleston, H. M., Papa, E. F. és mtsai: Repair after cholestatic liver injury correlates with neutrophil infiltration and matrix metalloproteinase 8 activity. Surgery, 2005, 138, 313-320.
7. Hochstadetr, H., Bekavac-Beslin, M., Doko, M. és mtsai: Functional liver damage during laparoscopic cholecystectomy as the sign of the late common bile duct stricture development. Hepatogastroenterology, 2003, 50, 676-679.
8. Horváth, A., Bíró, A.: Anti-cholesterol antibodies in human sera. Autoimmunity Reviews, 2003, 2, 272-277.
9. Koch, M., Pfohl, M., Enderle, M. és mtsai: Detection of the apolipoprotein B-100 arg(3500)>gl mutation in familial defective apoB-100 by temperature-gradient gel electrophoresis. Z. Gastroenterol., 1996, 34S, 16-18.
10. Lengyel G., Fehér J.: Terhességi cholestasis. Orv. Hetil., 2004, 145, 2103-2105.
11. Lengyel G., Fehér J., Gardo S. és mtsa: Ursodeoxy-cholsav-kezelés intrahepaticus terhességi cholestasisban egy eset kapcsán. Orv. Hetil., 2002, 143, 2885-2888.
12. MacFayden, B. V., Vecchio, R., Ricardo, A. E. és mtsai: Bile duct injury after laparoscopic cholecystectomy. Surg. Endosc., 1998, 12, 315-321.
13. Maisonette, F., Abita, T, Barriere, E. és mtsai: The MDR3 gene mutation: a rare cause of progressive familial intrahepatic cholestasis (PFIC). Ann. de Chirurgie, 2005, 130, 581-583.
14. Nuzzo, G., Giuliante, F., Giovannini, I. és mtsai: Bile Duct Injury During Laparoscopic Cholecystectomy. Arch. Surg., 2005, 140, 986-992.
15. Park, J. R., Jung, T. S., Jung, J. H. és mtsai: A Case of Hypothyoidism and Type 2 Diabetes Associated with Type V Hyperlipoproteinemia and Eruptive Xanthomas. J. Korean Med. Sci., 2005, 20, 502-505.
16. Parker, F.: Xanthomas and hyperlipidemias. J. Am. Acad. Dermatol., 1985, 13, 1-30.
17. Parl, F., Gulstein, W. H., D'Aguillo, A. F. és mtsai: Endothelial injury. Association with elevations of serum bile acid and cholesterol concentration in biliary-obstructed rats. Atherosclerosis, 1975, 21, 135-146.
18. Richardson, M. C., Bell, G., Fullarton, G. M. és mtsai: Incidence and nature of bile duct injuries following laparoscopic cholecystectomy: an audit of 5913 cases. Br. J. Surg., 1996, 83, 1356-1360.
19. Rodriguez-Garay, E. A., Rodriguez, G. P., Pisani, G. és mtsai: Reversible cholestasis induced by experimental partial obstruction of the bile duct; Biochemical, morphometric and hepatic transport kinetic studies. Pathophysiology, 2004, 11, 7-15.
20. Rosenson, R. S., Baker, A. L., Chow, M. J. és mtsai: Hyperviscosity syndrome in a hypercholesterolemic patient with primary biliary cirrhosis. Gastroenterology, 1990, 98, 1351-1357.
21. Russel, J. C., Walsh, S. J., Mattie, A. S. és mtsai: Bile duct injuries, 1989-1993: a statewide experience. Arch. Surg., 1996, 131, 382-388.
22. Sanchez Bayle, M., baeza Minguez, J., Vila Dupla, S. és mtsai: Lipoprotein(a) in children with hypercholesterolemia as a marker of the familial history of cardiovascular risk. The Working Group on Cardiovascular Rsok Factors in Childhood and Adolescence. An. Esp. Pediatr., 1996, 45, 53-56.
23. Schmidt, H. H., Manns, M. P.: Image sin hepatology. Regression of xanthelasmas in a patient with primary biliary cirrhosis after liver transplantation. J. Hepatol., 1998, 28, 1077.
24. Simmons, T. C: Distal common bile duct stricture and secondary biliary cirrhosis due to choledocholithiasis. J. Natl. Med. Assoc., 1991, 83, 1105-1108.
25. Sorkin, S. C., Forestiero, F. J., Hirata, M. H. és mtsai: APOAI polymorphisms are associated with variations in serum triglyceride concentrations in hypercholesterolemic individuals. Clin. Chem. Lab. Med., 2005, 43, 1339-1345.
26. Sperlongano, P., Pisaniello, D., Del Viscovo, L. és mtsai: Efficacy of magnetic resonance cholangiopancreatography in detecting common bile duct lithiasis: our experience. Chit. Ital., 2005, 57, 635-640.
27. Sportelli, G., Crovaro, M., Mercuri, M. és mtsai: Conservative approach in the treatment of the biliary tract's iatrogenic lesions. Eur. Rev. Med. Pharmacol. Sci., 2000, 4, 123-126.
28. Szalay, F., Kadar J., Zalka, A. és mtsai: Repeated plasma exchange for xanthomatosis in a case of primara biliary cirrhosis. Orv. Hetil., 1984, 125, 2797-2801.